Even though the number of patients in this subgroup was small, our results indicated a slight trend that the polymorphisms of both genes could explain the differences in TAM metabolism among BC patients.
← all excerpts
Effects of CYP2D6 and UGT2B7 polymorphisms on pharmacokinetics of tamoxifen in Thai breast cancer patients.
1
—
—